Tradestie Institutional Equity Comparison Engine

GERN vs ASTM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GERN Overall Edge

GERN Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Geron Corp (GERN) driven by superior Valuation, Growth & Margin while ASTM counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, GERN trades at 49.5x Forward P/E with -7.2% operating margin (+27.4% YoY revenue) versus ASTM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, GERN sits in BREAKDOWN (19th %ile IV; Dealer Gamma Walls on Pro) against ASTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner GERN
GERN 49.5x vs ASTM N/M Fwd P/E
Growth & Margin Winner GERN
Op Margin -7.2% vs N/A ยท YoY +27.4% vs N/A
Momentum & Technical Winner ASTM
1Y -19.4% vs +1.1% ยท 52W Pos 3% vs 53%
Options & Structure Winner ASTM
BREAKDOWN (19th %ile IV) vs UNCLASSIFIED (N/A IV)
GERN NASDAQ
Geron Corp
Pharmaceutical Preparations
$0.87
-4.63% 1D
Market Cap $588.2M
1M Return -22.95%
1Y Return -19.38%
Forward P/E 49.5x
Unified AI Score
48.4 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 65.0 Mom 64.0
ASTM US Equity
ASTM
Institutional Equity
$25.29
+0.08% 1D
Market Cap N/A
1M Return +0.52%
1Y Return +1.14%
Forward P/E N/M
Unified AI Score
50.6 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GERN -19.38% ASTM +1.14% Spread: +26.08 pp (ASTM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GERN TTM Op. Margin: -7.2% ASTM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GERN vs ASTM. Trailing 12-month operating profitability (GERN -7.2% vs ASTM N/A) and valuation multiples (GERN 49.5x vs ASTM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GERN (7) vs ASTM (3)
Institutional Metric GERN ASTM Criterion Row Winner
Market Capitalization Scale $588.2M N/A Larger Scale GERN
Trailing P/E Ratio Valuation 49.5x N/M Lower Multiple GERN
Forward P/E Ratio Valuation 49.5x N/M Lower Multiple GERN
Revenue Growth (YoY) Growth +27.4% N/A Higher Growth GERN
Operating Margin (TTM) Profitability -7.2% N/A Higher Margin GERN
Net Profit Margin Profitability -22.0% N/A Higher Margin GERN
Return on Equity (ROE) Capital Efficiency -20.1% N/A Higher ROE GERN
52-Week Range Position Momentum 3% ($1โ€“$2) 53% ($25โ€“$26) Stronger Trend ASTM
Beta / 30D Volatility Risk Regime 1.48ฮฒ ยท 102% Vol N/A Lower Realized Risk ASTM
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 50.6 / 100 (HOLD) Higher Composite ASTM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GERN vs ASTM Buy Guide
GERN BREAKDOWN
76d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 19th %ile
IV Regime Compressed (<25th %ile)
Live GERN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ASTM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ASTM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GERN nor ASTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.